Aktuelle Diagnostik und Therapie der Pneumocystis-jirovecii-Pneumonie

Schlüsselwörter

Pneumocystis-Pneumonie - HIV

Keywords

pneumocystis pneumonia - HIV

Literatur

• 1 Blum T, Roth A, Mauch H, Erbes R, Lode H. Pneumocystis jiroveci-Pneumonie bei immunsupprimierten Patienten ohne AIDS-Erkrankung – eine Fallserie.  Dtsch Med Wochenschr. 2006;  131 1515-1520
• 2 Calderón E J, Gutiérrez-Rivero S, Durand-Joly I, Dei-Cas E. Pneumocystis infection in humans: diagnosis and treatment.  Expert Rev Anti Infect Ther. 2010;  8 683-701
• 3 Carmona E M, Limper A H. Update on the diagnosis and treatment of Pneumocystis pneumonia.  Ther Adv Respir Dis. 2011;  5 41-59
• 4 Cheng V C, Yuen K Y, Chan W M, Wong S S, Ma E S, Chan R M. Immunorestitution disease involving the innate and adaptive response.  Clin Infect Dis. 2000;  3 882-892
• 5 Cohen R J, Sachs J R, Wicker D J, Conrad M E. Methemoglobinemia provoked by malarial chemoprophylaxis in Vietnam.  N Engl J Med. 1968;  279 1127-1131
• 6 Conte Jr J E, Chernoff D, Feigal Jr D W, Joseph P, McDonald C, Golden J A. Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. A randomized trial.  Ann Intern Med. 1990;  113 203-209
• 7 de Oliveira A, Unnasch T R, Crothers K, Eiser S, Zucchi P, Moir J, Beard C B, Lawrence G G, Huang L. Performance of a molecular viability assay for the diagnosis of Pneumocystis pneumonia in HIV-infected patients.  Diagn Microbiol Infect Dis. 2007;  57 169-176
• 8 Held J, Koch M, Reischl U, Danner T, Serr A. Serum (1-->3)-beta-D-Glucan measurement as early indicator for Pneumocystis jirovecii pneumonia and evaluation of its prognostic value.  Clin Microbiol Infect. 2011;  17 595-602
• 9 Helweg-Larsen J, Benfield T, Atzori C, Miller R F. Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study.  J Antimicrob Chemother. 2009;  64 1282-1290
• 10 Huang L, Crothers K. HIV-associated opportunistic pneumonias.  Respirology. 2009;  14 474-485
• 11 Katzung B G, Masters S B, Trevor A. Basic and Clinical Pharmacology. 11 Aufl. New York: McGraw-Hill Lange; 2010
• 12 Miller R F, Le Noury J, Corbett E L, Felton J M, De Cock K M. Pneumocystis carinii infection: current treatment and prevention.  J Antimicrob Chemother. 1996;  37 Suppl B 33-53
• 13 Mofenson L M, Brady M T, Danner S P. et al. Centers for Disease Control and Prevention; National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America; Pediatric Infectious Diseases Society; American Academy of Pediatrics . Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.  MMWR Recomm Rep. 2009;  58(RR-11) 1-166
• 14 Mu X D, Que C L, He B, Wang G F, Li H C. Caspofungin in salvage treatment of severe pneumocystis pneumonia: case report and literature review.  Chin Med J (Engl). 2009;  122 996-999
• 15 Navin T R, Beard C B, Huang L. et al . Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study.  Lancet. 2001;  358 545-549
• 16 Sattler F R, Frame P, Davis R. et al . Trimetrexate with leucovorin versus trimethoprim-sulfamethoxazole for moderate to severe episodes of Pneumocystis carinii pneumonia in patients with AIDS: a prospective, controlled multicenter investigation of the AIDS Clinical Trials Group Protocol 029/031.  J Infect Dis. 1994;  170 165-172
• 17 Short C E, Gilleece Y C, Fisher M J, Churchill D R. Trimetrexate and folinic acid: a valuable salvage option for Pneumocystis jirovecii pneumonia.  AIDS. 2009;  23 1287-1290
• 18 Thomas Jr C F, Limper A H. Current insights into the biology and pathogenesis of Pneumocystis pneumonia.  Nat Rev Microbiol. 2007;  5 298-308
• 19 Vanek J, Jirovec O. Parasitäre Pneumonie. Interstitielle Plasmazellenpneumonie der Frühgeborenen, verursacht durch Pneumocystis Carinii.  Zentralbl Bakteriol Parasitenkd Infektionskr Hyg. 1952;  158 120-127
• 20 Wells J, Haidaris C G, Wright T W, Gigliotti F. Active immunization against Pneumocystis carinii with a recombinant P. carinii antigen.  Infect Immun. 2006;  74 2446-2448